Background: Telemedicine expanded dramatically during the COVID-19 pandemic, transforming healthcare delivery worldwide. However, implementation faced challenges, and the impact on clinical outcomes, access, and quality remains under investigation. Objective: To systematically review the literature from 2020 to 2025 on telemedicine adoption, identifying key barriers and facilitators, and to evaluate clinical outcomes associated with telehealth use during this period. Methods: We followed PRISMA 2020 guidelines in conducting this review. Multiple databases were searched for studies on the implementation or evaluation of telemedicine/telehealth. Eligible studies included randomized trials and observational studies reporting telehealth-related outcomes, barriers, or facilitators. Two reviewers screened studies and extracted data on study characteristics, telemedicine interventions, barriers/facilitators, and clinical outcomes. Risk of bias was assessed using RoB2 for randomized controlled trials (RCTs) for qualitative or cross-sectional studies. Meta-analyses were performed where data were comparable, and qualitative synthesis was used to summarize barriers and facilitators. Results: Thirty-two studies (17 RCTs and 15 observational) were included. Telemedicine use surged in 2020 and remained elevated compared to baseline through August 2025. Reported barriers included insufficient broadband access, limited digital literacy, uncertain reimbursement policies, and workflow disruptions. Facilitators encompassed supportive policy waivers, the integration of telehealth into established care pathways, and strong acceptance from patients and providers. Clinical outcomes were generally comparable to in-person care. Telehealth enhanced chronic disease management (e.g., hypertension, diabetes) and decreased hospitalizations for heart failure, while ensuring safety in surgical follow-up and prenatal care. However, higher revisit rates were observed in some acute follow-up settings. Patient satisfaction consistently remained high, especially among rural and underserved populations reporting benefits, though disparities in digital access continued to exist. Conclusions: Telemedicine has become a sustainable component of healthcare, delivering clinical outcomes comparable to traditional care while offering convenience and resilience. Overcoming technology gaps, regulatory uncertainties, and equity issues is crucial for ongoing progress. Hybrid care models that combine telemedicine with in-person services, supported by strong policy frameworks, are recommended to maximize benefits and promote fair access in the post-pandemic era.
The COVID-19 pandemic accelerated a historic global growth of telehealth. In 2020, healthcare systems worldwide rapidly expanded telemedicine to maintain access while reducing the risk of infections [
1,
2]. Telehealth utilization statistics reflect this change: by late 2020, telehealth visit volumes had increased by over 3000% compared to 2019 [
2]. In the United States, among Medicare fee-for-service beneficiaries, telehealth accounted for 52.7 million clinician visits (5% of all FFS visits) in 2020, a 63-fold increase from about 0.84 million in 2019 [
3]. Telemedicine became an “indispensable resource” for maintaining patient care during lockdowns [
2,
4], supporting remote triage, chronic disease management, and mental health services when in-person care was limited.
This rapid digital health transformation revealed both opportunities and challenges. Telemedicine’s potential benefits include improved access (especially for rural or mobility-limited patients), efficiency and convenience in care delivery, and reduced exposure to contagion [
5,
6]. Indeed, early analyses revealed that telehealth effectively filled care gaps during the COVID-19 surges and could become a permanent part of healthcare systems [
7,
8]. At the same time, the pandemic-driven rollout of telemedicine revealed gaps and uncertainties. Many implementations happened on an ad hoc basis with limited guidelines or infrastructure [
9,
10,
11]. Policymakers and providers have since questioned the quality of care provided through telehealth, its impact on health outcomes and healthcare utilization, and its overall effect on health equity [
9,
11,
12]. Research gaps remain regarding whether telemedicine can fully replace in-person services without compromising care quality, which clinical areas benefit most, and how to overcome barriers such as limited technology access and provider/patient acceptance [
13,
14].
Although telemedicine research expanded rapidly during the COVID-19 pandemic, it remained fragmented across areas such as adoption barriers, digital equity, and clinical effectiveness, without integrating these domains into a single evaluative framework. Many early reviews focused on rapid deployment and short-term feasibility during the initial pandemic response [
2,
8], while others examined narrower themes, such as human-factor challenges or equity concerns. Several specialty-focused summaries assessed individual clinical areas. Notably, most of these reviews did not include meta-analyses or link implementation conditions with measurable clinical outcomes. Consequently, the field still lacks an updated, comprehensive synthesis explaining how barriers, facilitators, and system-level factors collectively influence telemedicine effectiveness across various care settings.
This review addresses that gap by synthesizing empirical evidence published from 2020 to 2025 through a PRISMA-guided systematic review and meta-analysis. The goal is to provide an integrated understanding of the determinants of telemedicine implementation and its clinical outcomes to inform sustainable digital health strategies and policy decisions.
The review was focused on three main research questions:
- (1)
-
What are the obstacles that prevented telemedicine from being widely adopted and effectively used during 2020–2025?
- (2)
-
What are the main factors that contribute to the successful implementation of telehealth?
- (3)
-
How did telemedicine impact clinical outcomes and healthcare utilization across different settings and patient groups?
By answering these questions, the study aims to extract lessons from the pandemic telehealth experience and offer recommendations for integrating telemedicine into sustainable, high-quality care models moving forward. Authoritative sources, such as the World Health Organization (WHO) and national agencies, have emphasized the importance of utilizing digital health beyond the pandemic. The study review also contextualizes findings within recent policy updates, such as the WHO’s 2022 telemedicine guidance and the U.S. telehealth law, to outline a path toward resilient hybrid care systems.
+1 credit
